First set of Medicare-negotiated “maximum fair prices” Now In Effect

Now

Users of 10 popular prescription drugs could benefit from lower drug prices that took effect at the start of the New Year. The degree of cost saving that will filter down to Medicare Part D users remains to be seen, however, due to the complexities of drug pricing across various plans. The 10 drugs on the list are: Eliquis, Enbrel, Entresto, Farxiga, Imbruvica, Januvia, Jardiance, NovoLog/Fiasp, Stelara and Xarelto. The Center Square’s Morgan Sweeney discusses the new pricing in a post on dallasexpress.com.

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.